NR4A1 and metastatic neoplasm: Presence of metastatic disease and missing HIV infection were associated with treatment non‐adherence (aOR: 1.85 and aOR: 2.13, respectively) while known hormone receptor status was associated with increased adherence (aOR: 0.18).